Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age

Since it was first identified in early November 2021, the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread quickly and replaced the B.1.617.2 (delta) variant as the dominant variant in many countries. Data on the real-world effectiveness of vacci...

Full description

Saved in:
Bibliographic Details
Main Authors: Tan, Sharon H. X., Cook, Alex R., Heng, Derrick, Ong, Benjamin, Lye, David C., Tan, Kelvin B.
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Article
Language:English
Published: 2023
Subjects:
Online Access:https://hdl.handle.net/10356/164086
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-164086
record_format dspace
spelling sg-ntu-dr.10356-1640862023-01-04T06:44:09Z Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age Tan, Sharon H. X. Cook, Alex R. Heng, Derrick Ong, Benjamin Lye, David C. Tan, Kelvin B. Lee Kong Chian School of Medicine (LKCMedicine) National Centre for Infectious Diseases Tan Tock Seng Hospital National University of Singapore Science::Medicine Urgent Care Encounters Vision Network Since it was first identified in early November 2021, the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread quickly and replaced the B.1.617.2 (delta) variant as the dominant variant in many countries. Data on the real-world effectiveness of vaccines against the omicron variant in children are lacking. 2023-01-04T06:44:08Z 2023-01-04T06:44:08Z 2022 Journal Article Tan, S. H. X., Cook, A. R., Heng, D., Ong, B., Lye, D. C. & Tan, K. B. (2022). Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age. New England Journal of Medicine, 387(6), 525-532. https://dx.doi.org/10.1056/NEJMoa2203209 0028-4793 https://hdl.handle.net/10356/164086 10.1056/NEJMoa2203209 35857701 2-s2.0-85136339464 6 387 525 532 en New England Journal of Medicine © 2022 Massachusetts Medical Society. All rights reserved.
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Science::Medicine
Urgent Care Encounters
Vision Network
spellingShingle Science::Medicine
Urgent Care Encounters
Vision Network
Tan, Sharon H. X.
Cook, Alex R.
Heng, Derrick
Ong, Benjamin
Lye, David C.
Tan, Kelvin B.
Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age
description Since it was first identified in early November 2021, the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread quickly and replaced the B.1.617.2 (delta) variant as the dominant variant in many countries. Data on the real-world effectiveness of vaccines against the omicron variant in children are lacking.
author2 Lee Kong Chian School of Medicine (LKCMedicine)
author_facet Lee Kong Chian School of Medicine (LKCMedicine)
Tan, Sharon H. X.
Cook, Alex R.
Heng, Derrick
Ong, Benjamin
Lye, David C.
Tan, Kelvin B.
format Article
author Tan, Sharon H. X.
Cook, Alex R.
Heng, Derrick
Ong, Benjamin
Lye, David C.
Tan, Kelvin B.
author_sort Tan, Sharon H. X.
title Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age
title_short Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age
title_full Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age
title_fullStr Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age
title_full_unstemmed Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age
title_sort effectiveness of bnt162b2 vaccine against omicron in children 5 to 11 years of age
publishDate 2023
url https://hdl.handle.net/10356/164086
_version_ 1754611283969179648